Kothekar K K - OmicsDI

Show results for

Unknown (5)
Proteomics (1)

Organisms

Alphavirus (1)
Anemia (1)
Archaea (1)
Bacteria (1)
Betaherpesvirinae (1)
Borrelia (1)
Chlamydomonas reinhardtii (1)
Clostridium perfringens (1)
Dengue virus (1)
Eukaryota (1)
Hepatitis B virus (1)
Human alphaherpesvirus 1 (1)
Human betaherpesvirus 5 (1)
Influenza A virus (1)
Influenza C virus (1)
Japanese encephalitis virus group (1)
Kamptonema sp. (1)
Listeria monocytogenes (1)
Mammarenavirus (1)
Miscanthus x giganteus (1)
Mus musculus (1)
Mycobacterium tuberculosis (1)
Orthoflavivirus (1)
Pseudomonas aeruginosa (1)
Rattus (1)
Sarbecovirus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Staphylococcus aureus (1)
Streptococcus pneumoniae (1)
Viruses (1)

Repository

pride (1)

Tissue

Glioblastoma cell line (1)

Technology Type

Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Mass Spectrometry (1)

Publication Date

2026 (1)

Release Date

2021 (3)
2025 (1)
2019 (1)

Lab affiliation

Professor. Neurological Surgery. Tong-Po Kan Chair in Neurological Surgery. UCSF Weill Institute for Neurosciences University of California San Francisco (UCSF) (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

TurboID proximity labelling and label free proteomic analysis of AURKB and ACP1 in GBM43 human glioblastoma cells

Here we are using unbiased proteomic analysis based on proximity labelling and TurboID coupled to MS to try to identify specific interactors of AURKB and ACP1 in GBM43 human glioblastoma cells.

ORGANISM(S): Homo sapiens (Human)

2026-05-18 | PXD077507 | Pride